{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:58:16Z","timestamp":1793987896469,"version":"4.8.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001652","name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001652","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease is a neurodegenerative disorder with no curative treatment option and objective biomarker profile. Extracellular Vesicles (EVs) are membrane-enclosed biological nanoparticles released from all cells of the human body. In this pilot study we compare plasma- and serum-derived EVs from Parkinson\u2019s disease (PD) patients and healthy controls (HC) utilizing a precipitation-based method. Additionally, we employ an L1CAM antibody to selectively enrich for L1CAM-positive EVs from the total plasma-\/serum-derived EV fractions. Successful EV enrichment was shown in western blot experiments for CD63 and for L1CAM as well as in metabolomic analysis for a HC sample. In a side-by-side quantification,. which we based on transmission electron microscopic images from negative stain samples, we identify small but significant differences between EV diameter from PD patients and HC. To streamline the quantification process, we introduce an ImageJ-based computer algorithm for (semi-)automated quantification of EVs from negative stain electron micrographs. We observe that this (semi-)automated quantification determines a smaller diameter than manual quantification. However, the difference between PD and HC group is systematic and reveals the same relative differences calculated from manually measured total plasma-derived EV particles. In this pilot study, we introduce a new workflow implemented into an ImageJ plugin enabling to determine differences in EV size within TEM images. For our data set of plasma-derived EVs from PD patients and HC, we find small, yet consistent differences. We feel that this study contributes to the search of a clinical biomarker for PD.<\/jats:p>","DOI":"10.1186\/s12964-025-02383-w","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T03:42:36Z","timestamp":1758166956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Transmission Electron Microscopy-based characterization of Extracellular Vesicles from plasma and serum from Parkinson\u00b4s Disease patients"],"prefix":"10.1186","volume":"23","author":[{"given":"Alexander","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Florin","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanni Annam\u00e1ria","family":"Boros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Regensburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina Verena","family":"Taudte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreu","family":"Matamoros-Angles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Zunke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"issue":"14","key":"2383_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12144","volume":"10","author":"Y Couch","year":"2021","unstructured":"Couch Y, et al. A brief history of nearly EV-erything - The rise and rise of extracellular vesicles. J Extracell Vesicles. 2021;10(14): e12144.","journal-title":"J Extracell Vesicles"},{"issue":"4","key":"2383_CR2","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1172\/JCI87316","volume":"126","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, Kroemer G, Zitvogel L. Extracellular vesicles: masters of intercellular communication and potential clinical interventions. J Clin Invest. 2016;126(4):1139\u201343.","journal-title":"J Clin Invest"},{"key":"2383_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020. https:\/\/doi.org\/10.1126\/science.aau6977.","journal-title":"Science"},{"issue":"4","key":"2383_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2383_CR5","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Yanez-Mo","year":"2015","unstructured":"Yanez-Mo M, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4: 27066.","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"2383_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","volume":"177","author":"M Poggio","year":"2019","unstructured":"Poggio M, et al. Suppression of Exosomal PD-L1 induces systemic Anti-tumor immunity and memory. Cell. 2019;177(2):414\u2013e42713.","journal-title":"Cell"},{"key":"2383_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2019.06.006","volume":"306","author":"JM Gudbergsson","year":"2019","unstructured":"Gudbergsson JM, et al. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity. J Control Release. 2019;306:108\u201320.","journal-title":"J Control Release"},{"issue":"6","key":"2383_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrrheum.2014.19","volume":"10","author":"EI Buzas","year":"2014","unstructured":"Buzas EI, et al. Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol. 2014;10(6):356\u201364.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"2383_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13(2): e12404.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2383_CR10","doi-asserted-by":"publisher","first-page":"e12397","DOI":"10.1002\/jev2.12397","volume":"13","author":"US Sandau","year":"2024","unstructured":"Sandau US, et al. Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies. J Extracell Vesicles. 2024;13(1):e12397.","journal-title":"J Extracell Vesicles"},{"issue":"12","key":"2383_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12385","volume":"12","author":"F Lucien","year":"2023","unstructured":"Lucien F, et al. MIblood-EV: minimal information to enhance the quality and reproducibility of blood extracellular vesicle research. J Extracell Vesicles. 2023;12(12): e12385.","journal-title":"J Extracell Vesicles"},{"key":"2383_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186466","author":"K Sidhom","year":"2020","unstructured":"Sidhom K, Obi PO, Saleem A. A review of exosomal isolation methods: is size exclusion chromatography the best option?? Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21186466.","journal-title":"Int J Mol Sci"},{"key":"2383_CR13","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v5.29497","volume":"5","author":"F Royo","year":"2016","unstructured":"Royo F, et al. Different EV enrichment methods suitable for clinical settings yield different subpopulations of urinary extracellular vesicles from human samples. J Extracell Vesicles. 2016;5: 29497.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2383_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1555419","volume":"8","author":"LG Rikkert","year":"2019","unstructured":"Rikkert LG, et al. Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent. J Extracell Vesicles. 2019;8(1): 1555419.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2383_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1596016","volume":"8","author":"D Bachurski","year":"2019","unstructured":"Bachurski D, et al. Extracellular vesicle measurements with nanoparticle tracking analysis - an accuracy and repeatability comparison between nanosight NS300 and ZetaView. J Extracell Vesicles. 2019;8(1): 1596016.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2383_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2017.1344087","volume":"6","author":"B Vestad","year":"2017","unstructured":"Vestad B, et al. Size and concentration analyses of extracellular vesicles by nanoparticle tracking analysis: a variation study. J Extracell Vesicles. 2017;6(1): 1344087.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2383_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020;27(1):27\u201342.","journal-title":"Eur J Neurol"},{"issue":"9996","key":"2383_CR18","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912.","journal-title":"Lancet"},{"issue":"6645","key":"2383_CR19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, et al. Alpha-synuclein in lewy bodies. Nature. 1997;388(6645):839\u201340.","journal-title":"Nature"},{"key":"2383_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00278","volume":"11","author":"M Mustapic","year":"2017","unstructured":"Mustapic M, et al. Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes. Front Neurosci. 2017;11: 278.","journal-title":"Front Neurosci"},{"issue":"10","key":"2383_CR21","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/mds.27362","volume":"33","author":"RB Postuma","year":"2018","unstructured":"Postuma RB, et al. Validation of the MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2018;33(10):1601\u20138.","journal-title":"Mov Disord"},{"issue":"4","key":"2383_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/mds.29317","volume":"38","author":"S Virameteekul","year":"2023","unstructured":"Virameteekul S, et al. Clinical diagnostic accuracy of Parkinson\u2019s disease: where do we stand?? Mov Disord. 2023;38(4):558\u201366.","journal-title":"Mov Disord"},{"issue":"34","key":"2383_CR23","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","volume":"27","author":"KM Danzer","year":"2007","unstructured":"Danzer KM, et al. Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci. 2007;27(34):9220\u201332.","journal-title":"J Neurosci"},{"issue":"1","key":"2383_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0467-z","volume":"5","author":"YJ Lim","year":"2017","unstructured":"Lim YJ, Lee SJ. Are exosomes the vehicle for protein aggregate propagation in neurodegenerative diseases? Acta Neuropathol Commun. 2017;5(1): 64.","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"2383_CR25","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.4103\/1673-5374.335143","volume":"17","author":"KL Li","year":"2022","unstructured":"Li KL, et al. Role of exosomes in the pathogenesis of inflammation in Parkinson\u2019s disease. Neural Regen Res. 2022;17(9):1898\u2013906.","journal-title":"Neural Regen Res"},{"key":"2383_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener. 2012;7: 42.","journal-title":"Mol Neurodegener"},{"key":"2383_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00038","volume":"13","author":"S Hornung","year":"2020","unstructured":"Hornung S, Dutta S, Bitan G. CNS-derived blood exosomes as a promising source of biomarkers: opportunities and challenges. Front Mol Neurosci. 2020;13: 38.","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"2383_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M, et al. Plasma Exosomal alpha-synuclein is likely CNS-derived and increased in parkinson\u2019s disease. Acta Neuropathol. 2014;128(5):639\u201350.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2383_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-021-02324-0","volume":"142","author":"S Dutta","year":"2021","unstructured":"Dutta S, et al. alpha-Synuclein in blood exosomes Immunoprecipitated using neuronal and oligodendroglial markers distinguishes parkinson\u2019s disease from multiple system atrophy. Acta Neuropathol. 2021;142(3):495\u2013511.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2383_CR30","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.mcn.2005.12.003","volume":"31","author":"J Faure","year":"2006","unstructured":"Faure J, et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci. 2006;31(4):642\u20138.","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"2383_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.mcn.2010.11.004","volume":"46","author":"G Lachenal","year":"2011","unstructured":"Lachenal G, et al. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci. 2011;46(2):409\u201318.","journal-title":"Mol Cell Neurosci"},{"issue":"6","key":"2383_CR32","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/hmg\/9.6.879","volume":"9","author":"S Kenwrick","year":"2000","unstructured":"Kenwrick S, Watkins A, De Angelis E. Neural cell recognition molecule L1: relating biological complexity to human disease mutations. Hum Mol Genet. 2000;9(6):879\u201386.","journal-title":"Hum Mol Genet"},{"key":"2383_CR33","doi-asserted-by":"crossref","unstructured":"Simpson RJ, Kalra H, Mathivanan S. ExoCarta as a resource for Exosomal research. J Extracell Vesicles. 2012;16:1.","DOI":"10.3402\/jev.v1i0.18374"},{"issue":"3","key":"2383_CR34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bpa.12370","volume":"26","author":"A Atik","year":"2016","unstructured":"Atik A, Stewart T, Zhang J. Alpha-synuclein as a biomarker for parkinson\u2019s disease. Brain Pathol. 2016;26(3):410\u20138.","journal-title":"Brain Pathol"},{"issue":"7","key":"2383_CR35","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/jnnp-2019-322588","volume":"91","author":"C Jiang","year":"2020","unstructured":"Jiang C, et al. Serum neuronal exosomes predict and differentiate Parkinson\u2019s disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry. 2020;91(7):720\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2383_CR36","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","volume":"30","author":"M Chatterjee","year":"2024","unstructured":"Chatterjee M, et al. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nat Med. 2024;30(6):1771\u201383.","journal-title":"Nat Med"},{"issue":"1","key":"2383_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jamaneurol.2023.4398","volume":"81","author":"S Yan","year":"2024","unstructured":"Yan S, et al. Neuronally derived extracellular vesicle alpha-Synuclein as a serum biomarker for individuals at risk of developing Parkinson disease. JAMA Neurol. 2024;81(1):59\u201368.","journal-title":"JAMA Neurol"},{"key":"2383_CR38","unstructured":"Total Exosome Isolation (from plasma), manual of the manufacturer (invitrogen by life technologies), publication no. MAN0008309, L. Technologies, version from 2013, please refer to: https:\/\/assets.thermofisher.com\/TFS-Assets\/LSG\/manuals\/total_exosome_plasma_man.pdf."},{"issue":"5","key":"2383_CR39","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/15548627.2022.2045534","volume":"18","author":"S Prieto Huarcaya","year":"2022","unstructured":"Prieto Huarcaya S, et al. Recombinant pro-CTSD (cathepsin D) enhances SNCA\/alpha-Synuclein degradation in alpha-Synucleinopathy models. Autophagy. 2022;18(5):1127\u201351.","journal-title":"Autophagy"},{"issue":"9","key":"2383_CR40","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/brain\/awac115","volume":"145","author":"A Kluge","year":"2022","unstructured":"Kluge A, et al. Detection of neuron-derived pathological alpha-synuclein in blood. Brain. 2022;145(9):3058\u201371.","journal-title":"Brain"},{"key":"2383_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-11-42","volume":"11","author":"P Arnold","year":"2014","unstructured":"Arnold P, et al. Antigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimers. Retrovirology. 2014;11: 42.","journal-title":"Retrovirology"},{"key":"2383_CR42","doi-asserted-by":"crossref","unstructured":"Mehdiani A et al. An innovative method for exosome quantification and size measurement. J Vis Exp. 2015;(95):50974.","DOI":"10.3791\/50974-v"},{"issue":"D1","key":"2383_CR43","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart DS, et al. HMDB 5.0: the human metabolome database for 2022. Nucleic Acids Res. 2022;50(D1):D622\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2383_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151339","volume":"11","author":"T Altadill","year":"2016","unstructured":"Altadill T, et al. Enabling metabolomics based biomarker discovery studies using molecular phenotyping of exosome-like vesicles. PLoS One. 2016;11(3): e0151339.","journal-title":"PLoS One"},{"issue":"7","key":"2383_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12089","volume":"10","author":"H Su","year":"2021","unstructured":"Su H, et al. Characterization of brain-derived extracellular vesicle lipids in Alzheimer\u2019s disease. J Extracell Vesicles. 2021;10(7): e12089.","journal-title":"J Extracell Vesicles"},{"key":"2383_CR46","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v2i0.20360","author":"KW Witwer","year":"2013","unstructured":"Witwer KW, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013. https:\/\/doi.org\/10.3402\/jev.v2i0.20360.","journal-title":"J Extracell Vesicles"},{"issue":"16","key":"2383_CR47","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","volume":"68","author":"B Gyorgy","year":"2011","unstructured":"Gyorgy B, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68(16):2667\u201388.","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"2383_CR48","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/jth.12602","volume":"12","author":"E van der Pol","year":"2014","unstructured":"van der Pol E, et al. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost. 2014;12(7):1182\u201392.","journal-title":"J Thromb Haemost"},{"key":"2383_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymeth.2015.02.019","volume":"87","author":"DD Taylor","year":"2015","unstructured":"Taylor DD, Shah S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods. 2015;87:3\u201310.","journal-title":"Methods"},{"issue":"1","key":"2383_CR50","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1697028","volume":"9","author":"Y Tian","year":"2020","unstructured":"Tian Y, et al. Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry. J Extracell Vesicles. 2020;9(1): 1697028.","journal-title":"J Extracell Vesicles"},{"key":"2383_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8545347","volume":"2018","author":"MY Konoshenko","year":"2018","unstructured":"Konoshenko MY, et al. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int. 2018;2018: 2018:p8545347.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2383_CR52","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1481321","volume":"7","author":"D Buschmann","year":"2018","unstructured":"Buschmann D, et al. Evaluation of serum extracellular vesicle isolation methods for profiling miRNAs by next-generation sequencing. J Extracell Vesicles. 2018;7(1): 1481321.","journal-title":"J Extracell Vesicles"},{"issue":"11","key":"2383_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12145","volume":"10","author":"J Guo","year":"2021","unstructured":"Guo J, et al. Establishment of a simplified dichotomic size-exclusion chromatography for isolating extracellular vesicles toward clinical applications. J Extracell Vesicles. 2021;10(11): e12145.","journal-title":"J Extracell Vesicles"},{"issue":"6","key":"2383_CR54","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41592-021-01174-8","volume":"18","author":"M Norman","year":"2021","unstructured":"Norman M, et al. L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma. Nat Methods. 2021;18(6):631\u20134.","journal-title":"Nat Methods"},{"issue":"6","key":"2383_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270634","volume":"17","author":"X Zhang","year":"2022","unstructured":"Zhang X, et al. Comparison of serum and plasma as a source of blood extracellular vesicles: increased levels of platelet-derived particles in serum extracellular vesicle fractions alter content profiles from plasma extracellular vesicle fractions. PLoS One. 2022;17(6): e0270634.","journal-title":"PLoS One"},{"issue":"8","key":"2383_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236439","volume":"15","author":"M Palviainen","year":"2020","unstructured":"Palviainen M, et al. Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo-implications for biomarker discovery. PLoS One. 2020;15(8): e0236439.","journal-title":"PLoS One"},{"key":"2383_CR57","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.aca.2018.03.009","volume":"1037","author":"X Liu","year":"2018","unstructured":"Liu X, et al. Serum or plasma, what is the difference? Investigations to facilitate the sample material selection decision making process for metabolomics studies and beyond. Anal Chim Acta. 2018;1037:293\u2013300.","journal-title":"Anal Chim Acta"},{"key":"2383_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering6010008","author":"E Serrano-Pertierra","year":"2019","unstructured":"Serrano-Pertierra E, et al. Characterization of plasma-derived extracellular vesicles isolated by different methods: a comparison study. Bioengineering. 2019. https:\/\/doi.org\/10.3390\/bioengineering6010008.","journal-title":"Bioengineering"},{"issue":"6","key":"2383_CR59","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.nano.2011.04.003","volume":"7","author":"RA Dragovic","year":"2011","unstructured":"Dragovic RA, et al. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine. 2011;7(6):780\u20138.","journal-title":"Nanomedicine"},{"key":"2383_CR60","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fncel.2018.00125","volume":"12","author":"S Cerri","year":"2018","unstructured":"Cerri S, et al. The exosomal\/total alpha-Synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients. Front Cell Neurosci. 2018;12:125.","journal-title":"Front Cell Neurosci"},{"key":"2383_CR61","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fnagi.2018.00438","volume":"10","author":"ZH Zhao","year":"2018","unstructured":"Zhao ZH, et al. Increased DJ-1 and alpha-Synuclein in plasma Neural-Derived exosomes as potential markers for parkinson\u2019s disease. Front Aging Neurosci. 2018;10:438.","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"2383_CR62","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/mds.28639","volume":"36","author":"A Stuendl","year":"2021","unstructured":"Stuendl A, et al. alpha-Synuclein in Plasma-Derived extracellular vesicles is a potential biomarker of parkinson\u2019s disease. Mov Disord. 2021;36(11):2508\u201318.","journal-title":"Mov Disord"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02383-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02383-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02383-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T05:02:35Z","timestamp":1758171755000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02383-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2383"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02383-w","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"395"}}